Surgical alternatives to transplantation and assist devices in the treatment of heart failure

Joseph DeRose, Mehmet C. Oz

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

It is estimated that in the United States 30,000 patients with end-stage heart disease are eligible for heart transplantation, although less than 2500 are actually performed each year. As the population ages, several thousand other patients who are ineligible for cardiac transplantation will be left with limited options. Surgical strategies aimed at halting the progression of heart failure have therefore been devised. High-risk coronary artery bypass grafting can improve ejection fraction and alleviate heart failure symptoms in appropriately selected patients. Mitral valve repair and ventricular aneurysm resection/plication procedures may improve heart failure by decreasing the volume load on the left ventricle. Myoreduction operations (Batista operation) aim to improve the volume and wall stress relationship of the dilated left ventricle, but their clinical application has remained experimental.

Original languageEnglish (US)
Pages (from-to)564-571
Number of pages8
JournalCurrent Cardiology Reports
Volume2
Issue number6
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Treatment Failure
Heart Failure
Transplantation
Heart Transplantation
Equipment and Supplies
Heart Ventricles
Mitral Valve
Coronary Artery Bypass
Aneurysm
Heart Diseases
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Surgical alternatives to transplantation and assist devices in the treatment of heart failure. / DeRose, Joseph; Oz, Mehmet C.

In: Current Cardiology Reports, Vol. 2, No. 6, 2000, p. 564-571.

Research output: Contribution to journalArticle

@article{2946ce54dfdf4321af9fa862e9200c0c,
title = "Surgical alternatives to transplantation and assist devices in the treatment of heart failure",
abstract = "It is estimated that in the United States 30,000 patients with end-stage heart disease are eligible for heart transplantation, although less than 2500 are actually performed each year. As the population ages, several thousand other patients who are ineligible for cardiac transplantation will be left with limited options. Surgical strategies aimed at halting the progression of heart failure have therefore been devised. High-risk coronary artery bypass grafting can improve ejection fraction and alleviate heart failure symptoms in appropriately selected patients. Mitral valve repair and ventricular aneurysm resection/plication procedures may improve heart failure by decreasing the volume load on the left ventricle. Myoreduction operations (Batista operation) aim to improve the volume and wall stress relationship of the dilated left ventricle, but their clinical application has remained experimental.",
author = "Joseph DeRose and Oz, {Mehmet C.}",
year = "2000",
doi = "10.1007/s11886-000-0043-0",
language = "English (US)",
volume = "2",
pages = "564--571",
journal = "Current Cardiology Reports",
issn = "1523-3782",
publisher = "Current Medicine Group",
number = "6",

}

TY - JOUR

T1 - Surgical alternatives to transplantation and assist devices in the treatment of heart failure

AU - DeRose, Joseph

AU - Oz, Mehmet C.

PY - 2000

Y1 - 2000

N2 - It is estimated that in the United States 30,000 patients with end-stage heart disease are eligible for heart transplantation, although less than 2500 are actually performed each year. As the population ages, several thousand other patients who are ineligible for cardiac transplantation will be left with limited options. Surgical strategies aimed at halting the progression of heart failure have therefore been devised. High-risk coronary artery bypass grafting can improve ejection fraction and alleviate heart failure symptoms in appropriately selected patients. Mitral valve repair and ventricular aneurysm resection/plication procedures may improve heart failure by decreasing the volume load on the left ventricle. Myoreduction operations (Batista operation) aim to improve the volume and wall stress relationship of the dilated left ventricle, but their clinical application has remained experimental.

AB - It is estimated that in the United States 30,000 patients with end-stage heart disease are eligible for heart transplantation, although less than 2500 are actually performed each year. As the population ages, several thousand other patients who are ineligible for cardiac transplantation will be left with limited options. Surgical strategies aimed at halting the progression of heart failure have therefore been devised. High-risk coronary artery bypass grafting can improve ejection fraction and alleviate heart failure symptoms in appropriately selected patients. Mitral valve repair and ventricular aneurysm resection/plication procedures may improve heart failure by decreasing the volume load on the left ventricle. Myoreduction operations (Batista operation) aim to improve the volume and wall stress relationship of the dilated left ventricle, but their clinical application has remained experimental.

UR - http://www.scopus.com/inward/record.url?scp=0034320117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034320117&partnerID=8YFLogxK

U2 - 10.1007/s11886-000-0043-0

DO - 10.1007/s11886-000-0043-0

M3 - Article

VL - 2

SP - 564

EP - 571

JO - Current Cardiology Reports

JF - Current Cardiology Reports

SN - 1523-3782

IS - 6

ER -